Kareem I. Batarseh; Filing of Food Additive Petition, 20145 [05-7727]
Download as PDF
Federal Register / Vol. 70, No. 73 / Monday, April 18, 2005 / Notices
and financial reports are due 90 days
after the close of the project period.
VII. Agency Contacts
Program Office Contact: Catherine
Beck, Administration for Children and
Families, Office of Community Services’
Operations Center, 1515 Wilson
Boulevard, Suite 100, Arlington, VA
22209, Phone: 1–800–281–9519, Fax:
703–528–0716, E-mail:
OCS@lcgnet.com.
Grants Management Office Contact:
Barbara Ziegler-Johnson, Administration
for Children and Families, Office of
Grants Management, Division of
Discretionary Grants, 370 L’Enfant
Promenade, SW., Aerospace Building,
Washington, DC 20447–0002, Phone: 1–
800–281–9519, Fax: 703–528–0716, Email: OCS@lcgnet.com.
VIII. Other Information
Notice: Beginning with FY 2006, the
Administration for Children and
Families (ACF) will no longer publish
grant announcements in the Federal
Register. Beginning October 1, 2005
applicants will be able to find a
synopsis of all ACF grant opportunities
and apply electronically for
opportunities via: www.Grants.gov.
Applicants will also be able to find the
complete text of all ACF grant
announcements on the ACF Web site
located at: https://www.acf.hhs.gov/
grants/.
The FY 2006 President’s budget does
not include or propose funding for the
Community Food and Nutrition
Program. Future funding is based on the
availability of Federal funds.
Direct federal grants, subaward funds,
or contracts under this community Food
and Nutrition Program shall not be used
to support inherently religious activities
such as religious instruction, worship,
or proselytization. Therefore,
organizations must take steps to
separate, in time or location, their
inherently religious activities from the
services funded under this Program.
Regulations pertaining to the
prohibition of Federal funds for
inherently religious activities can be
found on the HHS Web site at https://
www.os.HHS.gov/fbci/waisgate21.pdf.
Additional Information about this
program and its purpose can be located
on the following Web site: https://
www.acf.hhs.gov/programs/ocs.
Please reference Section IV.3 for
details about acknowledgement of
received applications.
VerDate jul<14>2003
16:08 Apr 15, 2005
Jkt 205001
20145
Dated: April 7, 2005.
Josephine B. Robinson,
Director, Office of Community Services.
[FR Doc. 05–7461 Filed 4–15–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4184–01–P
[Docket No. 2005D–0091]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005F–0138]
Kareem I. Batarseh; Filing of Food
Additive Petition
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Draft Guidance for Industry on User
Fee Waivers for Fixed Dose
Combination Products and CoPackaged Human Immunodeficiency
Virus Drugs for the President’s
Emergency Plan for Acquired
Immunodeficiency Syndrome Relief;
Availability
AGENCY:
The Food and Drug
Administration (FDA) is announcing
that Kareem I. Batarseh has filed a
petition proposing that the food additive
regulations be amended to provide for
the safe use of a mixture of hydrogen
peroxide, silver nitrate, phosphoric
acid, tartaric acid, glutamic acid, and
sodium tripolyphosphate as an
antimicrobial agent in bottled drinking
water.
FOR FURTHER INFORMATION CONTACT:
Mical E. Honigfort, Center for Food
Safety and Applied Nutrition (HFS–
265), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park,
MD 20740–3835, 301–436–1278.
SUPPLEMENTARY INFORMATION: Under the
Federal Food, Drug, and Cosmetic Act
(sec. 409 (b)(5) (21 U.S.C. 348(b)(5))),
notice is given that a food additive
petition (FAP 5A4759) has been filed by
Kareem I. Batarseh, P.O. Box 8, College
Park, MD 20741–0008. The petition
proposes to amend the food additive
regulations in part 172 Food Additives
Permitted For Direct Addition To Food
For Human Consumption (21 CFR part
172) to provide for the safe use of a
mixture of hydrogen peroxide, silver
nitrate, phosphoric acid, tartaric acid,
glutamic acid, and sodium
tripolyphosphate as an antimicrobial
agent in bottled drinking water.
The agency has determined under 21
CFR 25.32(k) that this action is of a type
that does not individually or
cumulatively have a significant effect on
the human environment. Therefore,
neither an environmental assessment
nor an environmental impact statement
is required.
Dated: April 1, 2005.
Laura M. Tarantino,
Director, Office of Food Additive Safety,
Center for Food Safety and Applied Nutrition.
[FR Doc. 05–7727 Filed 4–15–05; 8:45 am]
BILLING CODE 4160–01–S
Frm 00045
Fmt 4703
Sfmt 4703
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY:
PO 00000
Food and Drug Administration
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing the
availability of a draft guidance for
industry entitled ‘‘User Fee Waivers for
FDC and Co-Packaged HIV Drugs for
PEPFAR.’’ This draft guidance describes
the circumstances under which certain
applications for fixed dose combination
(FDC) and copackaged versions of
previously approved antiretroviral
therapies for the treatment of human
immunodeficiency virus (HIV) under
the President’s Emergency Plan for
Acquired Immunodeficiency Syndrome
Relief (PEPFAR) will not be assessed
user fees. The draft guidance also
describes circumstances under which
some of the applications that will be
assessed fees may be eligible for a
public health or a barrier-to-innovation
waiver.
DATES: Submit written or electronic
comments on the draft guidance by June
17, 2005. General comments on agency
guidance documents are welcome at any
time.
ADDRESSES: Submit written requests for
single copies of the draft guidance to the
Division of Drug Information (HFD–
240), Center for Drug Evaluation and
Research, Food and Drug
Administration, 5600 Fishers Lane,
Rockville, MD 20857. Send one selfaddressed adhesive label to assist that
office in processing your requests.
Submit written comments on the draft
guidance to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit
electronic comments to https://
www.fda.gov/dockets/ecomments. See
the SUPPLEMENTARY INFORMATION section
for electronic access to the draft
guidance document.
FOR FURTHER INFORMATION CONTACT:
Michael Jones, Center for Drug
Evaluation and Research (HFD–7), Food
and Drug Administration, 5600 Fishers
E:\FR\FM\18APN1.SGM
18APN1
Agencies
[Federal Register Volume 70, Number 73 (Monday, April 18, 2005)]
[Notices]
[Page 20145]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-7727]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. 2005F-0138]
Kareem I. Batarseh; Filing of Food Additive Petition
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing that
Kareem I. Batarseh has filed a petition proposing that the food
additive regulations be amended to provide for the safe use of a
mixture of hydrogen peroxide, silver nitrate, phosphoric acid, tartaric
acid, glutamic acid, and sodium tripolyphosphate as an antimicrobial
agent in bottled drinking water.
FOR FURTHER INFORMATION CONTACT: Mical E. Honigfort, Center for Food
Safety and Applied Nutrition (HFS-265), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740-3835, 301-436-1278.
SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic
Act (sec. 409 (b)(5) (21 U.S.C. 348(b)(5))), notice is given that a
food additive petition (FAP 5A4759) has been filed by Kareem I.
Batarseh, P.O. Box 8, College Park, MD 20741-0008. The petition
proposes to amend the food additive regulations in part 172 Food
Additives Permitted For Direct Addition To Food For Human Consumption
(21 CFR part 172) to provide for the safe use of a mixture of hydrogen
peroxide, silver nitrate, phosphoric acid, tartaric acid, glutamic
acid, and sodium tripolyphosphate as an antimicrobial agent in bottled
drinking water.
The agency has determined under 21 CFR 25.32(k) that this action is
of a type that does not individually or cumulatively have a significant
effect on the human environment. Therefore, neither an environmental
assessment nor an environmental impact statement is required.
Dated: April 1, 2005.
Laura M. Tarantino,
Director, Office of Food Additive Safety, Center for Food Safety and
Applied Nutrition.
[FR Doc. 05-7727 Filed 4-15-05; 8:45 am]
BILLING CODE 4160-01-S